The Clinical Characteristics of the Patients With Choledocholithiasis Without Cholangitis
Само регистрирани потребители могат да превеждат статии
Вход / Регистрация
Линкът е запазен в клипборда
Състояние
Спонсори
Gangnam Severance Hospital
КЛИНИЧНО ИЗСЛЕДВАНЕ: NCT02647593
BioSeek: NCT02647593
Ключови думи
Резюме
Laboratory change induced by common bile duct (CBD) stone is in general observed as the higher elevation of alkaline phosphatase (ALP) and gamma-glutamyl transpeptideas (ɤ-GT), in comparison to those of aspartate aminotransferase (AST) and alanine aminotransferase (ALT). However, some patients with CBD stone show the marked increased level of aminotransferase, which sometimes leads to misdiagnose those as liver disease caused by viral hepatitis, ischemia, and drug toxicity. The aim of this study is to investigate the clinicopathologic features of patients with CBD stones with the high level of aminotransferase in serum.
Дати
| Последна проверка: | 12/31/2015 |
| Първо изпратено: | 01/03/2016 |
| Очаквано записване подадено: | 01/03/2016 |
| Първо публикувано: | 01/05/2016 |
| Изпратена последна актуализация: | 01/03/2016 |
| Последна актуализация публикувана: | 01/05/2016 |
| Действителна начална дата на проучването: | 05/31/2006 |
| Приблизителна дата на първично завършване: | 09/30/2013 |
Състояние или заболяване
Choledocholithiasis
Фаза
-
Групи за ръце
| Arm | Интервенция / лечение |
|---|---|
| gallstone hepatitis group, gallstone hepatitis group (Among patients diagnosed as CBD stone who displayed above 400 IU/L of aminotransferase without cholangitis), | |
| control group control group (Among patients diagnosed as CBD stone who showed the normal value of aminotransferase) |
Критерии за допустимост
| Възрасти, отговарящи на условията за проучване | 20 Years Да се 20 Years |
| Полове, допустими за проучване | All |
| Метод за вземане на проби | Non-Probability Sample |
| Приема здрави доброволци | Да |
| Критерии | Inclusion Criteria: 1. patients were diagnosed with CBD stone under endoscopic retrograde cholangiopancreatography (ERCP) 2. patients showing above 400 IU/L of aminotransferase when at the first admitted into hospital and the control groups is the patients displaying normal AST and ALT. Exclusion Criteria: - 1. underlying hepatobiliary disease 2. alcoholics 3. cholangitis |
Резултат
Първични изходни мерки
1. clinicopathologic features of patients with CBD stones with the high level of aminotransferase [1year]
lab finding, radiologic images, and findings under ERCP such as CBD diameter, CBD stone diameter, CBD stone number, periampullary diverticulum.
